top of page

For Providers

The goal of personalized medicine is to individualize health care by using knowledge of patients’ health history, behaviors, environments, and, most importantly, genetic variation when making clinical decisions. Research on genetics has provided advances that can be used to more accurately predict the risk of developing certain diseases, personalize screening and surveillance protocols and, in some cases, prevent the onset of disease.

 

In certain cases, genetics can also be used to diagnose diseases and tailor therapies and disease management strategies. These advancements in personalized medicine rely on knowledge of how a patient’s genotype (genetic makeup) influences his or her phenotype (observable traits or characteristics). Using the principles of personalized medicine, health care providers may be better equipped to move beyond the “one-size-fits-all” approach that defined much of patient care in the past, to care that is appropriate for unique patient subgroups.  1

The types of Providers that benefit from the use of Prharmacogenetic Testing include:
Cardiologists
 

In a 3 year prospective study, in March 2008, the Mayo Clinic found that Warfarin phenotyping reduced the risk of hospitalizations by 31% in outpatients initiating warfarin.

Primary Care Physicians
 

The American Medical Association advocates that physicians become familiar with genetic variations that affect patients’ drug metabolism and be able to recognize when testing should be used to inform prescribing.

Pain Management

 

According to the AAPM Guidelines, initial treatment should always be considered individually determined, and as a trial of therapy–not a definitive course of treatment.

Psychiatrists
 

Two of the most prescribed medications for anxiety, Xanax (CYP3A4) and Celexa (CYP2C19) are metabolized differently.  Pharmacogenetic Testing increases the chance of proper dosage while increasing efficacy.

For information on how to add L Squared Personalized Medicine Program feauturing Pharmacogenetic Testing to your practice, contact us via email: Gregg.Lickstein@LSquaredHealthcare.com

1. Collins FS. 2010. The Future of Personalized Medicine. NIH Medline Plus 5(1):2–3.

bottom of page